Tijuana and Ciudad Juarez are Mexican cities bordering San Diego, California, and El Paso, Texas, respectively. The states of Baja California and Chihuahua, where these cities are located, are second and 14th among Mexico's 32 states in terms of cumulative AIDS incidence [1] . Commercial sex is quasilegal in the zonas rojas (red light districts) in most Mexican cities. There are an estimated 9000 female sex workers (FSWs) in Tijuana and 4000 in Ciudad Juarez [2] . Until relatively recently, HIV prevalence among FSWs in Mexico was low, although the prevalence of other sexually transmitted infections (STIs) among Mexican FSWs has been high for decades [3] .
In 2004 and 2005, we studied 155 FSWs in Tijuana and 140 FSWs in Ciudad Juarez and reported HIV seroprevalence values of 4.8% and 4.9%, respectively [2] . During the same period, a study of Ͼ1000 pregnant women at Tijuana General Hospital found that HIV prevalence was 1.1% [4] , which was suggestive of an emerging epidemic. Here, we describe HIV prevalence and correlates among a larger sample of FSWs in Tijuana and Ciudad Juarez through January 2006.
METHODS

Study population.
Between January 2004 and January 2006, outreach workers from municipal and community health clinics recruited 924 FSWs in Tijuana and Ciudad Juarez into a behavioral intervention study designed to increase condom use [2] . Eligibility requirements included age 18 years; trading of sex for drugs, money, or goods; and reporting of unprotected vaginal sex with 1 client in the past 2 months. Because one outcome for the behavioral intervention was HIV incidence, women were excluded if they reported having tested HIV positive before enrollment.
Data collection. Participants underwent intervieweradministered surveys in Spanish and provided a blood sample and a cervical swab sample, for which they were compensated $30 US. Interview topics included sociodemographics, sexual and substance use behaviors, working conditions, social influence, mood, self-esteem, social cognitive factors, and self-reported STIs.
HIV antibody was detected using the Determine rapid HIV antibody test (Abbott Pharmaceuticals); reactive samples were confirmed by EIA and Western blot. The rapid plasma reagin test was used to detect syphilis antibody (Macro-Vue; Becton Dickinson); reactive samples were confirmed by Treponema pallidum hemagglutinin assay (Fujirebio). Neisseria gonorrhoeae and Chlamydia trachomatis were detected from cervical swab using the APTIMA Combo-2 collection device (Gen-Probe). Pre-and posttest counseling was conducted; women with positive test results were referred to municipal health clinics for free medical care. STI tests and confirmatory HIV tests were conducted at either the San Diego County Health Department (for Tijuana samples) or the El Paso County Health Department (for Ciudad Juarez samples). Study protocols were reviewed and approved by institutional review boards in San Diego, Tijuana, and Ciudad Juarez.
Statistical analysis. Statistical analyses compared HIVpositive and HIV-negative FSWs, using Wilcoxon rank sum or Fisher's exact tests where appropriate. Univariate and multivariate logistic regressions were performed to identify factors associated with HIV-positive serostatus. In multivariate regressions, all variables attaining Ͻ10% significance were considered, from most to least significant; likelihood ratio tests were used to compare nested models, using a 5% significance level for variable inclusion. Pearson and Hosmer-Lemeshow tests were conducted to assess goodness of fit. Although site-specific models were examined, results are presented for the overall sample due to the relatively small number of HIV-positive cases and because site-specific associations were generally similar.
RESULTS
Of the 924 eligible FSWs enrolled (474 in Tijuana and 450 in Ciudad Juarez), 55 (6%) tested HIV positive. Only 2 falsepositive rapid HIV tests were observed. The median age was 32 years (interquartile range, 26 -39 years), one-fifth of the women spoke English (19.7%), and most had minimal education. Most women were married or living in a common-law arrangement; 93.7% had children (table 1) . Compared with HIV-negative FSWs, HIV-positive FSWs were significantly more likely to live in Tijuana (table 2), to have lived in the study site for longer durations, and to live in rented rooms. More than half of HIVpositive FSWs reported a steady partner who was an injection drug user, compared with a quarter of HIV-negative FSWs (odds ratio [OR], 3.59). There were no significant differences between groups in the amounts earned for protected and unprotected sex or the proportions describing themselves as street workers.
In terms of sexual and drug-use behaviors, HIV-positive FSWs had had significantly fewer clients in the past month than HIV-negative FSWs (median, 17 vs. 30 clients; P ϭ .008; OR, 0.99). However, this difference was confined to nonregular clients (median, 10 vs. 24 clients; P ϭ .005; OR, 0.99) as opposed to regular clients (median, 4 vs. 4 clients, P ϭ .73). In the past month, HIV-positive FSWs were more likely than HIV-negative FSWs to have had male clients who injected drugs (43.6% vs. 30.9%; P ϭ .05; OR, 1.73), to have injected drugs themselves (25.5% vs. 11.5%; P ϭ .005; OR, 2.63), or to have often or always used drugs before or during sex (36.4% vs. 12.8%; P Ͻ .001; OR, 3.89).
HIV-positive FSWs were more likely to have syphilis titers 1:8 (41.5% vs. 12.5%; P Ͻ .001; OR, 4.95) or to test positive for chlamydia (36.4% vs. 5.3%; P Ͻ .001; OR, 4.32) or gonorrhea (25.0% vs. 5.3%; P Ͻ .001; OR, 5.95). The high prevalence of STIs contrasted sharply with self-reported STI histories, which were markedly fewer and did not differ between groups.
In the final multivariate model (table 2) . These associations were essentially unchanged after adjustment for city of residence.
DISCUSSION
The findings of this large study of FSWs in 2 US-Mexico border cities indicate that HIV prevalence has increased significantly in the last decade. According to the criteria of the Joint United Nations Programme on HIV/AIDS, the HIV epidemics in both cities appear to have transitioned from low level to concentrated, because overall HIV prevalence among FSWs is now Ͼ5% [5] . FSWs who injected cocaine; who smoked, inhaled, or snorted methamphetamine; or whose syphilis titers were consistent with active infection were at least 3 times more likely to be HIVinfected compared with other FSWs. These findings have important implications for cross-border HIV transmission, because both cities adjoin busy ports of entry to the United States and are destinations for large numbers of sex tourists.
FSWs who used stimulants had greater odds of HIV infection, even if they did not inject. Injection drug use and sex work have been shown to overlap considerably in various settings [6 -9] . An elevated risk of HIV among injectors is not surprising; however, the independent association we observed between HIV infection and noninjection methamphetamine use was unexpected. Methamphetamine use has been closely associated with incident HIV infection among men who have sex with men [10] , but few studies have examined this association among heterosexuals. In one such study, in St. Petersburg, Russia, an independent association was reported between HIV infection and methamphetamine use among heterosexual-and predominantly male-injection drug users [11] . Use of stimulants, including methamphetamine and cocaine, has been associated with highrisk sexual behavior in FSWs and other populations [12] . A study of pregnant women in Tijuana found that HIV infection was independently associated with methamphetamine use, even after adjustment for injection drug use [4] , which mirrors our findings.
Although we did not observe an independent association between HIV infection and unprotected sex, methamphetamine use may be a proxy measure of high-risk sexual behaviors. Because methamphetamine production and use has risen dramatically in Mexico after crackdowns on its production in the United States [13] , it is important to identify whether the mechanism(s) responsible is directly or indirectly drug-related so that appropriate interventions can be developed. Volkow et al. suggested that stimulants induce sexual desire, which in turn could account for an increased frequency of high-risk sexual behaviors [14] . On the other hand, stimulant use could be a marker of sensation seeking or other personal attributes that are associated with higher levels of unprotected sex [10] . NOTE. Data are no. (%) of women, unless otherwise indicated. Certain percentages may reflect denominators smaller than the n value given in the column head. Except as specifically noted, these discrepancies are due to missing data. IDU, injection drug user; IQR, interquartile range; STI, sexually transmitted infection.
a For HIV-positive FSWs with steady partners, n ϭ 16; for HIV-negative FSWs with steady partners, n ϭ 277.
The finding that FSWs who inject cocaine were at an elevated risk of HIV infection is also cause for concern. These women may acquire HIV through sharing of needles or other injection paraphernalia, because cocaine injection is associated with frequent, more chaotic injection behavior. Alternatively, cocaine injection could be a marker of high-risk sexual behaviors, such as exchanging sex for drugs, which can compromise women's ability to negotiate safer sex. In our sample, the prevalence of HIV among FSWs who inject drugs was 12%, compared with 4% among FSWs who had never injected drugs [9] , which underscores the need for targeted interventions that reduce both sexual and injection risks in this vulnerable subgroup. Although subsidized drug abuse treatment exists in these Mexican cities, there are limited treatment options for persons addicted to stimulants, as in other countries.
Although many variables were significantly associated with HIV serostatus in univariate analyses, some variables, such as chlamydia and gonorrhea, were not independently associated with HIV infection after controlling for other factors (e.g., syphilis). Indeed, high syphilis titers were independently associated with a 4-fold odds of HIV infection, which is not surprising because syphilis is an important cofactor of HIV transmission. At enrollment, few women reported being aware of having an infectious STI, which could suggest that the majority of these infections were chronic and untreated or acute, incident infections. Although free treatment for syphilis and other STIs is available in Mexico under the country's universal health system, limited resources compromise the ability to conduct surveillance and provide treatment for high-risk populations. Recently, Mexico's federal and state ministries of health provided at least 2 mobile HIV/STI health clinics to most Mexican states in an effort to reach high-risk populations, an important first step toward a more active case-finding approach. Given the clear and immediate need for improved surveillance and aggressive STI treatment in both cities, binational funding strategies to improve financing and delivery of these services should be undertaken. Because HIV-positive FSWs were more likely to report that their regular partners and clients injected drugs, there is a concomitant need to develop interventions to reduce high-risk behaviors among these male partners. In a recent study we found that more than two-thirds of FSWs in Tijuana and Ciudad Juarez reported having US clients and that this subgroup tended to engage in higher-risk behaviors [15] , findings that underscore the necessity for a binational approach to preventive interventions among men who pay for sex.
The cross-sectional nature of this analysis limited our ability to draw causal inferences. Due to small sample sizes, we may have been underpowered to detect some associations (e.g., unprotected anal sex). Like most studies of sexual behavior, ours is potentially subject to socially desirable responding. Some women may have been aware of having an STI but were unwilling to report it, fearing that this would affect their ability to practice sex work. However, less than half reported consistent condom use for vaginal sex with clients, and the frequency of reported drug use was also high, suggesting that reporting bias may have been minimal. Because subjects were recruited through convenience sampling and eligibility criteria were designed to target high-risk women in need of intervention, our estimates of HIV/STI prevalence should not be generalized beyond the present sample. Indeed, HIV prevalence may be underestimated, because women who reported being HIV infected were excluded.
Although FSWs in Tijuana and Ciudad Juarez who use stimulants and have high syphilis titers are at increased risk of HIV infection, these risk factors are amenable to interventions. Our data emphasize the need for interventions to identify and treat ulcerative STIs and to reduce the risks associated with injection and noninjection use of stimulants. Multifaceted interventions need to be developed in a binational context to curtail the growing HIV epidemic among Mexican FSWs in these border communities.
